| Kristopher T Kahle, MD, PHD | |
|
282 Washington St, Hartford, CT 06106-3322 | |
| (860) 545-8373 | |
| (860) 545-8233 |
| Full Name | Kristopher T Kahle |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 17 Years |
| Location | 282 Washington St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063603181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 253454 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
| Entity Name | Boston Pediatric Neurosurgical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871523753 PECOS PAC ID: 2163491978 Enrollment ID: O20040929000096 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristopher T Kahle, MD, PHD P.o. Box 208082, Department Of Neurosurgery, Yale School Of Medicine, New Haven, CT 06511 Ph: () - | Kristopher T Kahle, MD, PHD 282 Washington St, Hartford, CT 06106-3322 Ph: (860) 545-8373 |
News Archive
A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.
Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.
Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
› Verified 7 days ago
Dr. Brendan Dyer Killory, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Seymour St, Suite 709, Hartford, CT 06106 Phone: 860-696-2290 Fax: 860-696-2280 | |
Dr. Paul Joseph Schwartz, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Retreat Ave, Suite 705, Hartford, CT 06106 Phone: 860-278-0070 Fax: 860-522-6081 | |
Dr. Stephan Charles Lange, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1000 Asylum Ave, Suite 3208, Hartford, CT 06105 Phone: 860-522-7121 Fax: 860-244-3516 | |
Kaveh Barami, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland Street, Hartford, CT 06105 Phone: 904-588-2596 | |
Dr. Jonathan Edward Martin, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 282 Washington St, Suite 1e, Hartford, CT 06106 Phone: 860-545-8373 Fax: 860-545-8233 | |
Joel A. Bauman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Seymour St, Suite 709, Hartford, CT 06106 Phone: 860-696-2290 Fax: 860-696-2280 |